Acadia Pharmaceuticals | Capitale Di Prestito



Loan Capital Cambiamento Data
Acadia Pharmaceuticals USD 0 0 2025-03
ALKERMES USD 0 0 2025-03
Alnylam Pharmaceuticals USD 1.03B 956K 2025-06
Biogen USD 6.28B 1.74B 2025-06
BioMarin Pharmaceutical USD 596.16M 512K 2025-06
Bristol-Myers Squibb USD 44.47B 1.69B 2025-06
Corcept Therapeutics USD 0 0 2025-03
Cytokinetics USD 713.04M 67.88M 2025-06
Eisai JPY 99.84B 9M 2025-06
Eli Lilly USD 34.18B 319.4M 2025-06
Incyte USD 31.76M 883K 2025-06
J&J USD 38.36B 7.7B 2025-03
Moderna USD 32M 3M 2025-06
Neurocrine Biosciences USD 0 0 2024-12
Pfizer USD 57.5B 137M 2025-06
Prothena USD 0 0 2024-12
PTC Therapeutics USD 2.13B 1.85B 2025-06
Sarepta Therapeutics USD 1.14B 1.17M 2025-06
Ultragenyx Pharmaceutical USD 782.75M 782.75M 2025-06
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12


Acadia Pharmaceuticals Capitale Di Prestito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.